United Therapeutics (UTHR) Reports In-Line Q4 EPS, Beats on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.11 -1.34%
EPS Growth %: -10.1%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: -10.1%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.89, in-line with the analyst estimate of $3.89. Revenue for the quarter came in at $464.7 million versus the consensus estimate of $420.9 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- RH (RH) Tops Q2 EPS by $2.31
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
